Allershausen, Germany

Stefan Trentmann

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Allerhausen, DE (2015)
  • Allershausen, DE (2015 - 2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Trentmann

Introduction

Stefan Trentmann, an accomplished inventor based in Allershausen, Germany, has made significant strides in the field of biotechnology. With a remarkable portfolio of 9 patents, Trentmann focuses on developing novel solutions that contribute to medical advancements. His innovative work primarily revolves around tear lipocalin and its implications in receptor binding.

Latest Patents

Among Trentmann's latest patents are the innovative muteins derived from human tear lipocalin, specifically designed to bind to the IL-4 receptor alpha. These inventions are characterized by unique combinations of amino acids, with specific mutated residues at designated sequence positions within the linear polypeptide sequence of mature human tear lipocalin. The patents also encompass corresponding nucleic acid molecules encoding these muteins, along with methodologies for their production, showcasing a pivotal advancement in therapeutic applications.

Career Highlights

Throughout his career, Trentmann has collaborated with esteemed companies in the biotechnology sector. Notably, he has worked with Pieris Pharmaceuticals GmbH and Pieris AG, where he has contributed to innovative projects that leverage his expertise in molecular biology and biochemistry.

Collaborations

Trentmann has had the pleasure of working alongside talented professionals such as Andreas Hohlbaum and Gabriele Matschiner. These collaborations have fostered an environment of creativity and innovation, allowing for the development of groundbreaking solutions in his field.

Conclusion

Stefan Trentmann's contributions to biotechnology, particularly through his patents involving tear lipocalin muteins, exemplify the importance of innovation and collaboration in advancing medical science. His dedication and expertise continue to pave the way for future advancements in therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…